| Product Name | MF | CAS | Details |
|---|
| Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
| Lorlatinib;PF0643922 | C21H19FN6O2 | 1454846-35-5 | Details |
| Crizotinib | C21H22Cl2FN5O | 877399-52-5 | Details |
| AP26113 | C26H34ClN6O2P | 1197958-12-5 | Details |
| Cabozantinib S-MALATE | C32H30FN3O10 | 1140909-48-3 | Details |
| Afatinib dimaleate | C28H29ClFN5O7 | 850140-73-7 | Details |
| Poziotinib | C23H21Cl2FN4O3 | 1092364-38-9 | Details |
| Solithromycin | C43H65FN6O10 | 760981-83-7 | Details |
| AMG-510 | C30H30F2N6O3 | 2252403-56-6 | Details |
| Trametinib | C26H23FIN5O4 | 871700-17-3 | Details |
| Dabrafenib | C23H20F3N5O2S2 | 1195765-45-7 | Details |
| Brigatinib;AP26113 | C29H39ClN7O2P | 1197953-54-0 | Details |
| LOXO-292 | C29H31N9O3 | 2222755-14-6 | Details |
| Regorafenib monohydrate | C21H17ClF4N4O4 | 1019206-88-2 | Details |
| Neratinib maleate | C34H33ClN6O7 | 915942-22-2 | Details |
| AZD3759 | C22H23ClFN5O3 | 1626387-80-1 | Details |
| Niraparib Tosylate | C26H28N4O4S | 1613220-15-7 | Details |
| Ripretinib | C24H21BrFN5O2 | 1442472-39-0 | Details |
| ABT-199 | C45H50ClN7O7S | 1257044-40-8 | Details |
| INCB28060;Dihydrochloride | C23H18ClFN6O | 1197376-85-4 | Details |
| PLX-4720 | C17H14ClF2N3O3S | 918505-84-7 | Details |
| BKM-120 Hydrochloride | C18H22ClF3N6O2 | 1312445-63-8 | Details |
| Dabrafenib Mesylate | C24H24F3N5O5S3 | 1195768-06-9 | Details |
| TAK-788 | C32H39N7O4 | 1847461-43-1 | Details |
| Selumetinib;AZD6244 | C17H15BrClFN4O3 | 606143-52-6 | Details |
| Eltrombopag olamine | C27H29N5O5 | 496775-62-3 | Details |
| MK-1775 | C27H32N8O2 | 955365-80-7 | Details |
| Ceritinib | C28H36ClN5O3S | 1032900-25-6 | Details |
| EAI045 | C19H14FN3O3S | 1942114-09-1 | Details |
| TPX-0005 | C18H18FN5O2 | 1802220-02-5 | Details |
| INCB28060;Capmatinib | C23H17FN6O | 1029712-80-8 | Details |
| Entrectinib | C31H34F2N6O2 | 1108743-60-7 | Details |
| Larotrectinib sulfate | C21H24F2N6O6S | 1223405-08-0 | Details |
| RXDX-106 | C31H26F2N4O6 | 1437321-24-8 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||